共 42 条
[1]
Hanauer SB(2002)Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial Lancet 359 1541-1549
[2]
Feagan BG(2004)Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease Gastroenterology 126 402-413
[3]
Lichtenstein GR(2009)Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease Inflamm Bowel Dis 15 1295-1301
[4]
Rutgeerts P(2006)Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn’s disease Gastrointest Endosc 63 433-442
[5]
Feagan BG(2010)Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease Gastroenterology 138 463-468
[6]
Lichtenstein GR(2007)Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort Gastroenterology 133 412-422
[7]
Schnitzler F(2014)Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011 Gut 63 1607-1616
[8]
Fidder H(2003)Clinical course and longterm prognosis of Japanese patients with Crohn’s disease: predictive factors, rates of operation, and mortality J Gastroenterol 38 942-953
[9]
Ferrante M(2002)Crohn’s colitis: experience with segmental resections; results in a series of 84 patients J Am Coll Surg 194 448-453
[10]
Rutgeerts P(1996)The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn’s disease Ann Surg 223 253-260